Sanjiv Patel - Apr 23, 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Signature
/s/ Brian Adams, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
Apr 23, 2025
Transactions value $
-$182,423
Form type
4
Date filed
4/24/2025, 04:03 PM
Previous filing
Feb 13, 2025
Next filing
Jul 1, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$127K -42.8K -4.84% $2.97 840K Apr 23, 2025 Direct F1, F2
transaction RLAY Common Stock Sale -$55.4K -18.7K -2.22% $2.97 822K Apr 23, 2025 Direct F3, F4
holding RLAY Common Stock 200K Apr 23, 2025 By The Patel Family Irrevocable Trust of 2019 F5
holding RLAY Common Stock 687K Apr 23, 2025 By The SSP Irrevocable Trust of 2020 F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 95,295 shares of restricted stock units ("RSUs") on April 22, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 452,118 shares underlying RSUs.
F3 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 41,558 shares of RSUs on April 22, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F4 Includes 410,560 shares underlying RSUs.
F5 These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.